PatentVest Welcomes Dr. Sarah Cork as Senior Patent Attorney, Expanding Life Sciences IP Leadership
Rhea-AI Summary
PatentVest, a division of MDB Capital Holdings (NASDAQ: MDBH), has announced the appointment of Dr. Sarah Cork as Senior Patent Attorney. Dr. Cork brings over a decade of experience in biotechnology, pharmaceutical, and medical device intellectual property matters, complemented by a Ph.D. in Neuroscience.
Dr. Cork specializes in complex IP matters including recombinant technology, biologics, immunotherapies, gene therapy, and AI-enabled precision medicine. Her expertise spans patent litigation, prosecution, IP due diligence, and freedom-to-operate analyses, with significant experience in BPCIA cases and Hatch-Waxman matters.
Beyond her legal practice, Dr. Cork serves as President of the Los Angeles Intellectual Property Law Association and is active in the Pasadena Angels investor group and SBIR grant review process.
Positive
- Strengthens company's life sciences IP expertise with addition of experienced senior patent attorney
- Expands service capabilities in high-value areas including biologics, gene therapy, and AI-enabled precision medicine
- Enhances ability to handle complex patent litigation and regulatory matters
Negative
- None.
News Market Reaction – MDBH
On the day this news was published, MDBH declined 0.80%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Sarah Cork Ph.D. - Patent Attorney
Dallas, TX, Sept. 24, 2025 (GLOBE NEWSWIRE) -- PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is pleased to announce that Dr. Sarah Cork is collaborating with the firm as a Senior Patent Attorney. Her arrival underscores PatentVest’s continued growth in the life sciences sector and strengthens its ability to deliver sophisticated intellectual property strategies that drive competitive advantage for clients.
Dr. Cork brings more than a decade of experience advising biotechnology, pharmaceutical, and medical device companies on complex intellectual property matters. With a Ph.D. in Neuroscience, she counsels clients on a wide range of sophisticated issues involving recombinant technology, biologic and small-molecule drugs, immunotherapies, gene therapy, medical devices, and AI-enabled precision medicine, with a focus on translational drug discovery. Her legal practice combines scientific expertise with extensive experience in patent litigation, prosecution, IP due diligence, and freedom-to-operate analyses. She has advised clients ranging from venture-backed startups developing first-in-class therapies to global enterprises defending multibillion-dollar portfolios.
Dr. Cork’s cases under the Biologics Price Competition and Innovation Act (BPCIA), early at-risk launches. Her litigation background also spans Hatch-Waxman (ANDA) matters, post-grant proceedings, patent inventorship disputes, and drug product liability cases.
“Sarah’s arrival is a major win for our clients,” said Javier Chamorro, COO of PatentVest. “Her unique combination of deep scientific knowledge and proven litigation experience equips us to guide innovators through the most complex IP challenges—from protecting groundbreaking biologics to navigating regulatory pathways. Adding Sarah to our team strengthens PatentVest’s position as a trusted partner for life sciences companies and aligns with our broader mission to build enduring value for our clients and stakeholders.”
Beyond her legal practice, Dr. Cork is an active leader in the intellectual property and life sciences communities. She currently serves as the President of the Los Angeles Intellectual Property Law Association, is a member of the Pasadena Angels investor group, contributes as an SBIR grant reviewer, and entrepreneurs in life sciences incubators and accelerators.
About PatentVest
PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is the first integrated IP intelligence, strategy, and law firm designed to help visionary companies become technology leaders. By combining a proprietary database with a proven diligence process and deep technical expertise, PatentVest delivers actionable insights that protect innovation and empower clients to build lasting market leadership.
For more information or inquiries, please contact info@patentvest.com.
Attachment
FAQ
Who is Dr. Sarah Cork and what is her new role at PatentVest (NASDAQ: MDBH)?
What areas of expertise does Dr. Cork bring to PatentVest (NASDAQ: MDBH)?
What leadership roles does Dr. Cork hold outside of PatentVest?
How will Dr. Cork's appointment impact PatentVest's services?
